500 kids with muscular dystrophy to be tracked in major new study
NCT ID NCT07511920
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will follow 500 boys aged 1 to 18 with Duchenne or Becker muscular dystrophy for several years. Researchers will track their muscle function, body composition, lab tests, and heart and lung imaging to map how the disease changes over time. The goal is to create a model that predicts individual disease progression, which could help personalize care and future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict how the disease will progress in individual children and guide future treatment plans.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve symptoms or provide a cure. Results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Second University Hospital, Sichuan University
Chengdu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking muscle changes unlock better duchenne treatments?
- Robotic arm could help people with paralysis regain independence at home
- New study aims to sharpen tools for tracking becker muscular dystrophy
- New drug could help boys with duchenne walk and move longer
- Could a common ED drug and cycling help kids with duchenne?
- New powered brace aims to restore mobility for leg weakness patients